Empoder M
Description
Empagliflozin 12.5 mg + Metformin 500 mg - For Type 2 Diabetes Management
Key Features
- Dual-action therapy for enhanced glycemic control
- SGLT2 inhibitor promotes glucose excretion through urine
- Biguanide reduces glucose production in liver
- Improves insulin sensitivity
- Weight management benefits
- Cardiovascular protection
- Treats Type 2 Diabetes, Insulin Resistance, Metabolic Syndrome
